Journal article

Choosing and sequencing novel drugs in CLL: Dealing with an embarrassment of riches?

CS Tam, JF Seymour

Annals of Oncology | OXFORD UNIV PRESS | Published : 2017

DOI: 10.1093/annonc/mdx103

University of Melbourne Researchers

Citation metrics

1Scopus
1Web of Science
1Dimensions

Keywords

Cyclophosphamide
Regimen
Science & Technology
Chronic Lymphocytic-Leukemia
Fludarabine
3211 Oncology and Carcinogenesis
Ibrutinib
Venetoclax
3202 Clinical Sciences
Oncology
32 Biomedical and Clinical Sciences
Initial Therapy
Life Sciences & Biomedicine
Idelalisib
Rituximab